Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 924

1.

Retinal Imaging through Phakic Iris-Claw IOL.

Schuster AK, Kaplan N, Pfeiffer N, Dick HB, Vossmerbaeumer U.

Semin Ophthalmol. 2014 Jun 13:1-4. [Epub ahead of print]

PMID:
24926816
[PubMed - as supplied by publisher]
2.

A radiographic and clinical comparison of reamer-irrigator-aspirator versus iliac crest bone graft in ankle arthrodesis.

Nodzo SR, Kaplan NB, Hohman DW, Ritter CA.

Int Orthop. 2014 Jun;38(6):1199-203. doi: 10.1007/s00264-014-2348-4. Epub 2014 Apr 29.

PMID:
24770726
[PubMed - in process]
3.

JNC 8 or too much of a good thing.

Kaplan NM.

J Clin Hypertens (Greenwich). 2014 Apr;16(4):263-4. doi: 10.1111/jch.12284. No abstract available.

PMID:
24735491
[PubMed - in process]
4.

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.

Brooke MA, Etheridge SL, Kaplan N, Simpson C, O'Toole EA, Ishida-Yamamoto A, Marches O, Getsios S, Kelsell DP.

Hum Mol Genet. 2014 Aug 1;23(15):4064-76. doi: 10.1093/hmg/ddu120. Epub 2014 Mar 18.

PMID:
24643277
[PubMed - in process]
Free Article
5.

Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.

Kaplan N, Vituri A, Korczyn AD, Cohen OS, Inzelberg R, Yahalom G, Kozlova E, Milgrom R, Laitman Y, Friedman E, Rosset S, Hassin-Baer S.

J Mol Neurosci. 2014 Jun;53(2):183-8. doi: 10.1007/s12031-014-0276-9. Epub 2014 Mar 15.

PMID:
24633632
[PubMed - in process]
6.

Oncogenic RIT1 mutations in lung adenocarcinoma.

Berger AH, Imielinski M, Duke F, Wala J, Kaplan N, Shi GX, Andres DA, Meyerson M.

Oncogene. 2014 Jan 27. doi: 10.1038/onc.2013.581. [Epub ahead of print]

PMID:
24469055
[PubMed - as supplied by publisher]
7.

Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension.

Brinker S, Pandey A, Ayers C, Price A, Raheja P, Arbique D, Das SR, Halm EA, Kaplan NM, Vongpatanasin W.

J Am Coll Cardiol. 2014 Mar 4;63(8):834-5. doi: 10.1016/j.jacc.2013.10.067. Epub 2013 Dec 4. No abstract available.

PMID:
24315901
[PubMed - indexed for MEDLINE]
8.

High-throughput genome scaffolding from in vivo DNA interaction frequency.

Kaplan N, Dekker J.

Nat Biotechnol. 2013 Dec;31(12):1143-7. doi: 10.1038/nbt.2768. Epub 2013 Nov 24.

PMID:
24270850
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Short to midterm clinical and radiographic outcomes of the salto total ankle prosthesis.

Nodzo SR, Miladore MP, Kaplan NB, Ritter CA.

Foot Ankle Int. 2014 Jan;35(1):22-9. doi: 10.1177/1071100713510497. Epub 2013 Oct 24.

PMID:
24157645
[PubMed - in process]
10.

[Postspinal subacut subdural hematoma: case report].

Doğanay F, Pirbudak L, Gül R, Alptekin M, Kaplan N.

Agri. 2013 Jul;25(3):129-32. doi: 10.5505/agri.2013.76598. Turkish.

PMID:
24104535
[PubMed - in process]
Free Article
11.

AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects.

Kaplan N, Garner C, Hafkin B.

Eur J Pharm Sci. 2013 Nov 20;50(3-4):440-6. doi: 10.1016/j.ejps.2013.08.019. Epub 2013 Aug 27. Erratum in: Eur J Pharm Sci. 2014 Feb 14;52:223.

PMID:
23988847
[PubMed - indexed for MEDLINE]
12.

Furosemide for your mother?

Kaplan NM.

J Am Soc Hypertens. 2013 Nov-Dec;7(6):507-8. doi: 10.1016/j.jash.2013.06.005. Epub 2013 Aug 13. No abstract available.

PMID:
23948429
[PubMed - in process]
13.

Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism.

Kaplan N.

Hypertension. 2013 Oct;62(4):e13. doi: 10.1161/HYPERTENSIONAHA.113.01754. Epub 2013 Aug 5. No abstract available.

PMID:
23918755
[PubMed - indexed for MEDLINE]
14.

Effects of baking on cyanidin-3-glucoside content and antioxidant properties of black and yellow soybean crackers.

Slavin M, Lu Y, Kaplan N, Yu LL.

Food Chem. 2013 Nov 15;141(2):1166-74. doi: 10.1016/j.foodchem.2013.04.039. Epub 2013 Apr 23.

PMID:
23790899
[PubMed - indexed for MEDLINE]
15.

Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252.

Parsons JB, Kukula M, Jackson P, Pulse M, Simecka JW, Valtierra D, Weiss WJ, Kaplan N, Rock CO.

Antimicrob Agents Chemother. 2013 May;57(5):2182-90. doi: 10.1128/AAC.02307-12. Epub 2013 Mar 4.

PMID:
23459481
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model.

Banevicius MA, Kaplan N, Hafkin B, Nicolau DP.

J Chemother. 2013 Feb;25(1):26-31. doi: 10.1179/1973947812Y.0000000061.

PMID:
23433441
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

In vitro activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics.

Kaplan N, Awrey D, Bardouniotis E, Berman J, Yethon J, Pauls HW, Hafkin B.

J Chemother. 2013 Feb;25(1):18-25. doi: 10.1179/1973947812Y.0000000063.

PMID:
23433440
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis.

Gordon K, Kochkodan JJ, Blatt H, Lin SY, Kaplan N, Johnston A, Swindell WR, Hoover P, Schlosser BJ, Elder JT, Gudjonsson JE, Getsios S.

J Invest Dermatol. 2013 Mar;133(3):712-22. doi: 10.1038/jid.2012.391. Epub 2012 Nov 29.

PMID:
23190894
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor.

Kaplan N, Albert M, Awrey D, Bardouniotis E, Berman J, Clarke T, Dorsey M, Hafkin B, Ramnauth J, Romanov V, Schmid MB, Thalakada R, Yethon J, Pauls HW.

Antimicrob Agents Chemother. 2012 Nov;56(11):5865-74. doi: 10.1128/AAC.01411-12. Epub 2012 Sep 4.

PMID:
22948878
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Primary aldosteronism: evidence against a second epidemic.

Kaplan NM.

J Hypertens. 2012 Oct;30(10):1899-902. doi: 10.1097/HJH.0b013e3283559a03.

PMID:
22929608
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk